Articles Tagged With: Implants
-
Tamoxifen for the Management of Bleeding Irregularities in Contraceptive Implant Users
In this double-blind, randomized controlled trial, etonogestrel implant users with prolonged or frequent menses who took 10 mg of tamoxifen twice daily for seven days as needed for irregular bleeding had an average of 9.8 (95% confidence interval, 4.6-15.0) more consecutive days of amenorrhea over a 90-day period compared to those who took a placebo.
-
Etonogestrel Contraceptive Implant and VTE in Postpartum Women
In this national retrospective cohort study of postpartum women, use of the etonogestrel contraceptive implant immediately postpartum was not associated with an increased rate of readmission for venous thromboembolism within 30 days of delivery.
-
Contraceptive Implants Are an Option for Patients Taking Isotretinoin
When clinicians prescribe the acne medication isotretinoin, they advise reproductive-age women to avoid pregnancy through two different contraceptives and an online iPledge app. Since the drug causes severe birth defects, it is important young women do not become pregnant while taking the drug. Etonogestrel contraceptive implants could be one contraceptive option for women taking isotretinoin, but there are concerns the acne drug would decrease the effectiveness of hormonal contraceptives.
-
Injectable Implant Focus of HIV Treatment/ Prevention Research
Researchers with the University of North Carolina at Chapel Hill and the Centers for Disease Control and Prevention are examining a new drug delivery system that uses dolutegravir, an established HIV drug, in a potential longacting treatment and prevention system. The system has been tested in animal models.
-
Check Your Clinical Practice for LARC Methods
The American College of Obstetricians and Gynecologists now recognizes immediate postpartum placement of either the intrauterine device or the contraceptive implant as a best practice because of the long-acting reversible contraceptive methods’ role in preventing rapid repeat and unintended pregnancy
-
Training Can Help Integrate LARC Options Into Contraceptive Care
Research from the Bixby Center for Global Reproductive Health at the University of California, San Francisco, and Planned Parenthood Federation of America indicates that a four-hour training intervention can significantly affect the likelihood that healthcare providers will integrate long-acting reversible contraceptives into their clinical care.
-
Time to Update Your Knowledge of Long-Acting Reversible Contraceptives
Practice bulletin says intrauterine, implant options are safe and effective for almost all women.
-
More Teens Using Contraception, Data Show
While more relying on IUDs and other methods, pill use remains common
-
Extending Life of LARCs: More Years for Your Implant
An international study found that continued use of an etonogestrel contraceptive implant for up to five years, two years longer than the current labeling approval, did not increase the risk of pregnancy.
-
Update on Contraceptive Implant — What Family Planners Need to Know
The contraceptive implant Nexplanon (Merck, Whitehouse Station, NJ) offers top-tier effectiveness against unintended pregnancy. How can you identify appropriate candidates, present counseling tips on the contraceptive and noncontraceptive benefits, and recognize and treat side effects and rare complications?